"The promise of SBDD for GPCRs is that rational design can now be used to identify and optimise ligands that bind challenging or undruggable GPCR targets," said Fiona Marshall, Heptares' Chief ...

The companies will collaborate to prioritize the GPCR targets using Sosei Heptares’ world-leading StaR® (stabilized receptor) platform and structure-based drug design expertise, with the goal ...

Collaboration to create transformative therapeutics for immune diseases by combining InveniAI's validated AI-based platform, AlphaMeld®, with Sosei Heptares' GPCR Structure-based Drug Design and ...

Methodological advances in X-ray crystallography have made possible the recent solution of X-ray structures of pharmaceutically important G protein-coupled receptors (GPCRs), including receptors for ...

A mere six months ago Verily launched the study with Sosei Heptares – a global leader in GPCR structure-based drug design – with an aim to “prioritise protein targets for therapeutic ...

"GPCR structure: Research reveals molecular origins of function for a key drug target." ScienceDaily. ScienceDaily, 21 December 2023. <www.sciencedaily.com / releases / 2023 / 12 / 231221162230.htm>.

Ainnocence unveils AI for antibody affinity and GPCR design via SentinusAI®. Mapping 59 GPCR families, 175 targets, and 444 indications for advanced drug design SAN FRANCISCO , CALIFORNIA, UNITED ...